A 4-year-old girl was admitted to pediatric intensive care unit due to Reye’s syndrome. Her medical history was notable for recurrent episodes of hypoglycemia when ill. Plasma levels of acylcarnitines and free carnitine (C0) were not remarkable, but creatine kinase (CK) level was increased (1674 U/l). A muscle biopsy was performed that showed severe and diffuse accumulation of lipid in muscle fibers (Fig. 1). Acylcarnitine profile was reviewed. Liver isoform of carnitine palmitoyltransferase IA (CPTIA) deficiency was suspected because of the increased C0/ [palmitoylcarnitine (C16) + stearoylcarnitine (C18)] ratio: 2190 (normal value 266–1510). With dietary treatment, rapid and dramatic improvement was observed. Two novel variants in the CPT1A gene were found: c.627delT (severe mutation) and c.1006G > A (predicted as damaging by several bioinformatic algorithms).
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.